Clinical Trial: Efficacy and Safety of a Single Dose of Emodepside Compared to a Single Dose of Albendazole in Adolescents and Adults Infected With Trichuris Incognita

U.S., Dec. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07258173) titled 'Efficacy and Safety of a Single Dose of Emodepside Compared to a Single Dose of Albendazole in Adolescents and Adults Infected With Trichuris Incognita' on Nov. 20.

Brief Summary: The purpose of this clinical trial is to compare the efficacy and safety of emodepside, with the standard treatment, albendazole, in adolescents (12 years and older) and adults infected with Trichuris incognita.

Study Start Date: Jan. 15, 2026

Study Type: INTERVENTIONAL

Condition: Trichuris Infection Trichuris

Intervention: DRUG: Emodepside

Treatment with 15 mg of emodepside

DRUG: Albendazole 400 mg

Treatment with 400mg of albendazole

Recruitment ...